02197.HK
Clover Biopharmaceuticals, Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 2.10
+3.96%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -2.83x
- Price / sales
- 43.50x
- Price / cash flow
- -6.96x
Enterprise value
- Enterprise value
- HKD 2.5B
- EV / sales
- 41.53x
- EV / EBITDA
- -1.92x
- EV / EBIT
- -1.83x
- Market cap
- HKD 2.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026